Abstract
Minimal change nephrotic syndrome (MCNS) cases achieving spontaneous remission without external factors are rarely reported. We report a case of MCNS that achieved spontaneous remission without external factors that triggered its onset. An 82-year-old male patient was admitted to the hospital for close examination of nephrotic syndrome. Renal biopsy was performed and MCNS was diagnosed. Owing to the patient’s age and history of foot and microvascular arteriovenous thrombosis, we did not start immunosuppressive drugs, including steroids, and opted for conservative management. After conservative treatment, proteinuria gradually decreased, and the patient achieved complete remission. Given that the patient had a history of urinary protein and thrombosis, recurrence of MCNS was considered again this time. In addition, the involvement of external factors that trigger the onset of MCNS was not found. In conclusion, in elderly-onset MCNS, clinicians generally hesitate to initiate treatment with an immunosuppressive drug, containing steroids, because of its many complications. Thus, our data provide valuable insight into MCNS.
Similar content being viewed by others
References
Yamamoto R, Imai E, Maruyama S, et al. Incidence of remission and relapse of proteinuria, end-stage kidney disease, mortality, and major outcomes in primary nephrotic syndrome: the Japan nephrotic syndrome cohort study (JNSCS). Clin Exp Nephrol. 2020;24:526–40.
Vivarelli M, Massella L, Ruggiero B, Emma F. Minimal change disease. Clin J Am Soc Nephrol. 2017;12:332–45.
Fujimoto S, Yamamoto Y, Hisanaga S, Morita S, Eto T, Tanaka K. Minimal change nephrotic syndrome in adults: response to corticosteroid therapy and frequency of relapse. Am J Kidney Dis. 1991;17:687–92.
Takei T, Koike M, Suzuki K, et al. The characteristics of relapse in adult-onset minimal-change nephrotic syndrome. Clin Exp Nephrol. 2007;11:214–7.
Kikuchi H, Aoyagi M, Nagahama K, et al. Nephrotic-range proteinuria and interstitial nephritis associated with the use of a topical loxoprofen patch. Intern Med. 2014;53:1131–5.
Yamashiro A, Uchida T, Ito S, Oshima N, Oda T, Kumagai H. Complete remission of minimal change disease following an improvement of lung mycobacterium avium infection. Intern Med. 2016;55:2669–72.
Haruki A, Ishikawa E, Katayama K, et al. Spontaneous remission of adult-onset minimal change nephrotic syndrome associated with influenza B infection. BMC Nephrol. 2018;19:162.
Black DA, Rose G, Brewer DB. Controlled trial of prednisone in adult patients with the nephrotic syndrome. Br Med J. 1970;3:421–6.
McDonough AK, Curtis JR, Saag KG. The epidemiology of glucocorticoid-associated adverse events. Curr Opin Rheumatol. 2008;20:131–7.
Stuijver DJF, Majoor CJ, Van Zaane B, et al. Use of oral glucocorticoids and the risk of pulmonary embolism: a population-based case-control study. Chest. 2013;143:1337–42.
Yokoyama H, Sugiyama H, Narita I, et al. Outcomes of primary nephrotic syndrome in elderly japanese: retrospective analysis of the Japan renal biopsy registry (J-RBR). Clin Exp Nephrol. 2015;19:496–505.
Mak SK, Short CD, Mallick NP. Long-term outcome of adult-onset minimal-change nephropathy. Nephrol Dial Trans. 1996;11:2192–201.
Sharp W, Olivero JJ. Venous thrombosis in nephrotic syndrome. Methodist Debakey Cardiovasc J. 2018;14:237–8.
Nakayama M, Katafuchi R, Yanase T, Ikeda K, Tanaka H, Fujimi S. Steroid responsiveness and frequency of relapse in adult-onset minimal change nephrotic syndrome. Am J Kidney Dis. 2002;39:503–12.
Ponticelli C, Glassock RJ. Glomerular diseases: membranous nephropathy-a modern view. Clin J Am Soc Nephrol. 2014;9:609–16.
Moorthy AV, Zimmerman SW. Renal disease in the elderly: clinicopathologic analysis of renal disease in 115 elderly patients. Clin Nephrol. 1980;14:223–9.
Kanahara K, Yorioka N, Kumagai J, et al. A case of nephrotic syndrome with rapid spontaneous remission in an elderly patient. Hiroshima J Med Sci. 1997;46:93–7.
Işlek I, Gök F, Albayrak D, Küçüködük S. Nephrotic syndrome following cefixime therapy in a 10-month-old girl: spontaneous resolution without corticosteroid treatment. Nephrol Dial Transplant. 1999;14:2527.
Ferrara P, Gatto A, Vitelli O, Liberatore P, Del Bufalo F, Bottaro G. Nephrotic syndrome following H1N1 influenza in a 3-year-old boy. Iran J Pediatr. 2012;22:265–8.
Lin CY, Hsu HC. Histopathological and immunological studies in spontaneous remission of nephrotic syndrome after intercurrent measles infection. Nephron. 1986;42:110–5.
Kron MA, Hedger R. Hepatitis A-induced remission of minimal change nephropathy. Arch Intern Med. 1984;144:2279–80.
Shalhoub RJ. Pathogenesis of lipoid nephrosis: a disorder of T-cell function. Lancet. 1974;2:556–60.
Lai KW, Wei CL, Tan LK, et al. Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats. J Am Soc Nephrol. 2007;18:1476–85.
Cheung W, Wei CL, Seah CC, Jordan SC, Yap HK. Atopy, serum IgE, and interleukin-13 in steroid-responsive nephrotic syndrome. Pediatr Nephrol. 2004;19:627–32.
Garin EH, Mu W, Arthur JM, et al. Urinary CD80 Is elevated in minimal change disease but not in focal segmental glomerulosclerosis. Kidney Int. 2010;78:296–302.
Ishimoto T, Shimada M, Araya CE, Huskey J, Garin EH, Johnson RJ. Minimal change disease: a CD80 podocytopathy? Semin Nephrol. 2011;31:320–5.
Kim AH, Chung JJ, Akilesh S, et al. B cell-derived IL-4 acts on podocytes to induce proteinuria and foot process effacement. JCI Insight. 2017;2:e81836.
Reiser J, von Gersdorff G, Loos M, et al. Induction of B7–1 in podocytes is associated with nephrotic syndrome. J Clin Invest. 2004;113:1390–7.
Komatsuda A, Wakui H, Iwamoto K, et al. GATA-3 Is upregulated in peripheral blood mononuclear cells from patients with minimal change nephrotic syndrome. Clin Nephrol. 2009;71:608–16.
Iwabuchi Y, Takei T, Moriyama T, Itabashi M, Nitta K. Long-term prognosis of adult patients with steroid-dependent minimal change nephrotic syndrome following rituximab treatment. Medicine (Baltimore). 2014;93:e300.
Miyabe Y, Takei T, Iwabuchi Y, Moriyama T, Nitta K. Amelioration of the adverse effects of prednisolone by rituximab treatment in adults with steroid-dependent minimal-change nephrotic syndrome. Clin Exp Nephrol. 2016;20:103–10.
Iwabuchi Y, Moriyama T, Itabashi M, Takei T, Nitta K. Rituximab as a therapeutic option for steroid-sensitive minimal change nephrotic syndrome in adults. Contrib Nephrol. 2018;195:12–9.
Christiansen CF, Schmidt M, Lamberg AL, et al. Kidney Disease and risk of venous thromboembolism: a nationwide population-based case-control study. J Thromb Haemost. 2014;12:1449–54.
Mahmoodi BK, Ten Kate MK, Waanders F, et al. High Absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome: results from a large retrospective cohort study. Circulation. 2008;117:224–30.
Ismail G, Mircescu G, Ditoiu AV, Tacu BD, Jurubita R, Harza M. Risk factors for predicting venous thromboembolism in patients with nephrotic syndrome: focus on haemostasis-related parameters. Int Urol Nephrol. 2014;46:787–92.
Lionaki S, Derebail VK, Hogan SL, et al. Venous thromboembolism in patients with membranous nephropathy. Clin J Am Soc Nephrol. 2012;7:43–51.
Wattanakit K, Cushman M, Stehman-Breen C, Heckbert SR, Folsom AR. Chronic kidney disease increases risk for venous thromboembolism. J Am Soc Nephrol. 2008;19:135–40.
Ribic C, Crowther M. Thrombosis and anticoagulation in the setting of renal or liver disease hematology. Am Soc Hematol Educ Program. 2016;2:188–95.
Kumar S, Chapagain A, Nitsch D, Yaqoob MM. Proteinuria and hypoalbuminemia are risk factors for thromboembolic events in patients with idiopathic membranous nephropathy: an observational study. BMC Nephrol. 2012;13:107.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors have declared that no conflict of interest exists.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed consent
Informed consent was obtained from the patient described in this study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Chiba, Y., Nagasawa, T., Kin, S. et al. Spontaneous remission of minimal change nephrotic syndrome in an elderly man. CEN Case Rep 10, 301–307 (2021). https://doi.org/10.1007/s13730-020-00554-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13730-020-00554-x